pentobarbital will decrease the level or outcome of lumacaftor/ivacaftor by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.pentobarbital will lessen the extent or result of repaglinide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.Following oral or parenteral administration, barbiturat